ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 610459 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 610459; 2) Community: the network communities that were significantly associated with the response to NSC 610459; 3) Molecule: the relationships between components within communities and NSC 610459; 4) MDR: the compounds that were significantly associated with the NSC 610459.

NSC Compound Enrichment Correlation
NSC 658145 2-(2-(Dimethylamino)ethylamino)naphthazarin 0.0376362543535811 0.040379975
NSC 666783 Pyrido[2,3-d]pyrimidine-2,4-diamine, 6-[[(4-methoxy- phenyl)amino]methyl]-5-methyl-, 3/5 methanol 0.0376362543535811 0.36602676
NSC 673320 Null 0.0376362543535811 -0.034616436
NSC 681684 2-Trifluoroethoxy-6-oxoestra-1,3,5(10)-trien-3,17.beta.-diol 0.0376362543535811 0.22955242
NSC 706031 Null 0.0376362543535811 -0.081231101
NSC 174121 Methotrexate Derivative 0.0376362543535815 0.58082076
NSC 39351 Null 0.0376362543535815 -0.056196548
NSC 335787 1-Piperazinecarbothioic acid, 4-(2-pyridinyl)-, [1-(6-methyl-2-pyridinyl)ethylidene]hydrazide 0.038267585766958 0.038150196
NSC 102627 Yoshi 864 0.0382675857669585 0.72637852
NSC 166641 6H-Furo[2',3':4,5]oxazolo[3,2-a]pyrimidine-2-methanol, 7-fluoro-2,3,3a,9a-tetrahydro-3-hydroxy-6-imino-, monohydrochloride 0.0382675857669585 0.49307307
Total:64  Current:50    [First] [Prev] [Next] [Last]